| Issue Date | Title | Author(s) |
| 2016 | Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy | Pednekar, L; Valentino, A; Ji, Y; Tumma, N; Valentino, C; Kadoor, A; Hosszu, KK; Ramadass, M; Kew, RR; Kishore, U; Peerschke, EIB; Ghebrehiwet, B |
| 2016 | Surfactant protein D induces immune quiescence and apoptosis of mitogen-activated peripheral blood mononuclear cells | Pandit, H; Thakur, G; Koippallil Gopalakrishnan, AR; Dodagatta-Marri, E; Patil, A; Kishore, U; Madan, T |
| 2016 | Mesenchymal stem cells: a promising tool for targeted gene therapy of Endometriosis | Gopalakrishnan, ARK; Kishore, U; Madan, T |
| 2013 | Human surfactant protein D alters oxidative stress and HMGA1 expression to induce p53 apoptotic pathway in eosinophil leukemic cell line | Mahajan, L; Pandit, H; Madan, T; Gautam, P; Yadav, AK; Warke, H; Sundaram, CS; Sirdeshmukh, R; Sarma, PU; Kishore, U; Surolia, A |
| 2018 | Editorial: Macromolecular Structure Underlying Recognition in Innate Immunity | Kishore, U |
| 2018 | Pathological significance and prognostic value of Surfactant Protein D in cancer | Mangogna, A; Belmonte, B; Agostinis, C; Giuseppe, R; Gulino, A; Ferrara, I; Zanconati, F; Tripodo, C; Romano, F; Kishore, U; Bulla, R |
| 2014 | Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages | Pondman, KM; Sobik, M; Nayak, A; Tsolaki, AG; Jäkel, A; Flahaut, E; Hampel, S; ten Haken, B; Sim, RB; Kishore, U |
| 2018 | Is the a-chain the engine that drives the diversity of C1q functions? Revisiting its unique structure | Ghebrehiwet, B; Kandov, E; Kishore, U; Peerschke, EIB |
| 5-Feb-2018 | Fungal melanin stimulates surfactant protein D-mediated opsonization of and host immune response to Aspergillus fumigatus spores | Wah Wong, SS; Rani, M; Dodagatta-Marri, E; Ibrahim-Granet, O; Kishore, U; Bayry, J; Latgé, JP; Sahu, A; Madan, T; Aimanianda, V |
| 2016 | A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway | Kouser, L; Abdul-Aziz, M; Tsolaki, AG; Singhal, D; Schwaeble, WJ; Urban, BC; Khan, HA; Sim, RB; Kishore, U |
